Relmada Therapeutics, Inc. is a clinical stage, private biopharmaceutical company focused on developing novel versions of proven drug products that potentially address areas of high unmet medical need for the treatment of chronic pain. The Company has a deep and diversified portfolio of four lead productsat different stages of development and an early stage pipeline of an additional three products.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/25/12 | $3,000,000 | Series A |
BioAdvance Wonpung Mulsan | undisclosed |
